PMID | Title | Journal | Publication Year | Author | View in RVdb |
---|---|---|---|---|---|
30844608 | New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling. | Eur J Med Chem | 2019 | Kassem AF;Batran RZ;Abbas EMH;Elseginy SA;Shaheen MNF;Elmahdy EM | View More |
32313408 | Discovery of anti-SARS coronavirus drug based on molecular docking and database screening. | Chin J Chem | 2004 | Chen HF;Yao JH;Sun J;Li Q;Li F;Fan BT;Yuan SG | View More |
33713730 | Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. | Antiviral Res | 2021 | Milani M;Donalisio M;Bonotto RM;Schneider E;Arduino I;Boni F;Lembo D;Marcello A;Mastrangelo E | View More |
33932782 | Sub-structure-based screening and molecular docking studies of potential enteroviruses inhibitors. | Comput Biol Chem | 2021 | James SA;Yam WK | View More |
34708566 | Discovery of Inhibitors for Mycobacterium Tuberculosis Peptide Deformylase Based on Virtual Screening in Silico. | Mol Inform | 2022 | Li X;Jiang Q;Yang X | View More |
34821198 | In silico screening and covalent binding of phytochemicals of Ocimum sanctum against SARS-CoV-2 (COVID 19) main protease. | J Biomol Struct Dyn | 2023 | Mohapatra PK;Chopdar KS;Dash GC;Mohanty AK;Raval MK | View More |
35165507 | Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology. | Int J Med Sci | 2022 | Li J;Zhang K;Bao J;Yang J;Wu C | View More |
35625804 | Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease. | Biomedicines | 2022 | Gambacorta N;Caputo L;Quintieri L;Monaci L;Ciriaco F;Nicolotti O | View More |